Insider Selling: Danaher (NYSE:DHR) SVP Sells $4,773,952.48 in Stock

Danaher Corporation (NYSE:DHR) SVP Brian Ellis sold 21,776 shares of Danaher stock in a transaction dated Wednesday, November 12th. The shares were sold at an average price of $219.23, for a total transaction of $4,773,952.48. Following the transaction, the senior vice president directly owned 14,553 shares of the company’s stock, valued at $3,190,454.19. This represents a 59.94% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.

Danaher Price Performance

Shares of Danaher stock opened at $221.25 on Friday. The stock has a market capitalization of $156.28 billion, a price-to-earnings ratio of 45.62, a P/E/G ratio of 3.28 and a beta of 0.81. The firm’s 50-day moving average price is $205.63 and its two-hundred day moving average price is $201.10. The company has a current ratio of 1.52, a quick ratio of 1.10 and a debt-to-equity ratio of 0.33. Danaher Corporation has a 1-year low of $171.00 and a 1-year high of $258.23.

Danaher (NYSE:DHR) last posted its earnings results on Monday, October 20th. The conglomerate reported $1.89 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.72 by $0.17. The company had revenue of $6.05 billion during the quarter, compared to analysts’ expectations of $6 billion. Danaher had a net margin of 14.44% and a return on equity of 10.92%. Danaher’s quarterly revenue was up 4.4% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.71 earnings per share. On average, equities analysts predict that Danaher Corporation will post 7.63 earnings per share for the current fiscal year.

Danaher Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, October 31st. Shareholders of record on Friday, September 26th were paid a $0.32 dividend. The ex-dividend date of this dividend was Friday, September 26th. This represents a $1.28 dividend on an annualized basis and a yield of 0.6%. Danaher’s payout ratio is currently 26.39%.

Analyst Upgrades and Downgrades

A number of analysts have recently weighed in on the company. TD Cowen raised their target price on Danaher from $250.00 to $260.00 and gave the company a “buy” rating in a research note on Wednesday, October 22nd. Deutsche Bank Aktiengesellschaft increased their price objective on shares of Danaher from $235.00 to $250.00 and gave the stock a “buy” rating in a report on Wednesday, October 22nd. Wells Fargo & Company reaffirmed a “positive” rating on shares of Danaher in a research note on Thursday, October 23rd. Guggenheim reissued a “buy” rating and set a $250.00 price target on shares of Danaher in a research note on Wednesday, July 23rd. Finally, UBS Group lowered their price target on shares of Danaher from $240.00 to $225.00 and set a “buy” rating for the company in a report on Wednesday, July 23rd. Eighteen research analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $243.39.

Hedge Funds Weigh In On Danaher

Several large investors have recently bought and sold shares of the business. Schonfeld Strategic Advisors LLC lifted its stake in shares of Danaher by 56.8% in the 3rd quarter. Schonfeld Strategic Advisors LLC now owns 169,993 shares of the conglomerate’s stock valued at $33,703,000 after purchasing an additional 61,610 shares during the period. L1 Capital International Pty Ltd lifted its stake in Danaher by 105.0% in the third quarter. L1 Capital International Pty Ltd now owns 98,938 shares of the conglomerate’s stock valued at $19,615,000 after buying an additional 50,684 shares during the period. Ashford Capital Management Inc. boosted its holdings in Danaher by 62.7% during the third quarter. Ashford Capital Management Inc. now owns 9,919 shares of the conglomerate’s stock worth $1,967,000 after buying an additional 3,821 shares during the last quarter. AQR Capital Management LLC grew its position in shares of Danaher by 65.1% during the 3rd quarter. AQR Capital Management LLC now owns 1,464,336 shares of the conglomerate’s stock worth $276,276,000 after buying an additional 577,462 shares during the period. Finally, NCM Capital Management LLC acquired a new position in shares of Danaher during the 3rd quarter worth about $226,000. 79.05% of the stock is currently owned by institutional investors and hedge funds.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.